PERKINELMER INC (PKI) Stock Overview
USA - NYSE:PKI - US7140461093 - Common Stock
PKI Key Statistics, Chart & Performance
The current stock price of PKI is 115.24 USD. In the past month the price decreased by -15.23%. In the past year, price decreased by -21.46%.
PKI Latest News, Press Relases and Analysis
PKI Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC | 24.62 | 203.50B | ||
| DHR | DANAHER CORP | 27.76 | 149.70B | ||
| BRKRP | BRUKER CORP - BRKR 6 3/8 09/01/28 | 139.64 | 45.55B | ||
| A | AGILENT TECHNOLOGIES INC | 26.04 | 40.23B | ||
| IQV | IQVIA HOLDINGS INC | 17.83 | 34.77B | ||
| MTD | METTLER-TOLEDO INTERNATIONAL | 32.99 | 27.80B | ||
| WAT | WATERS CORP | 27.36 | 19.91B | ||
| WST | WEST PHARMACEUTICAL SERVICES | 38.88 | 19.46B | ||
| TEM | TEMPUS AI INC | N/A | 15.25B | ||
| MEDP | MEDPACE HOLDINGS INC | 39.26 | 14.83B | ||
| ILMN | ILLUMINA INC | 22.95 | 14.67B | ||
| ICLR | ICON PLC | 13.99 | 14.39B |
Related stock screener links
About PKI
Company Profile
PerkinElmer, Inc. engages in the provision of products, services, and solutions for diagnostics, food, environmental, life sciences, and applied markets. The company is headquartered in Waltham, Massachusetts and currently employs 16,700 full-time employees. The firm operates through two segments: Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment provides products and services targeted towards the life sciences and applied markets. The Diagnostics segment develops diagnostics, tools and applications focused on clinically oriented customers, especially within the reproductive health, immunodiagnostics and applied genomics markets. Its products and services for Discovery & Analytical Solutions applications include The Opera Phenix Plus high-content screening system, The Operetta CLS high-content analysis system, The MuviCyte live-cell imaging system, and The Signals Image Artist. Its products and services for Diagnostics applications include The DELFIA Xpress screening platform, The Specimen Gate informatics data management solution and The DELFIA Xpress sFlt-1 kit.
Company Info
PERKINELMER INC
940 Winter Street
Waltham MASSACHUSETTS 02451 US
CEO: Prahlad Singh
Employees: 16700
Phone: 17816635776.0
PERKINELMER INC / PKI FAQ
What is the stock price of PERKINELMER INC today?
The current stock price of PKI is 115.24 USD. The price decreased by -0.91% in the last trading session.
What is the ticker symbol for PERKINELMER INC stock?
The exchange symbol of PERKINELMER INC is PKI and it is listed on the New York Stock Exchange, Inc. exchange.
On which exchange is PKI stock listed?
PKI stock is listed on the New York Stock Exchange, Inc. exchange.
What is the price forecast or stock price prediction for PERKINELMER INC stock?
20 analysts have analysed PKI and the average price target is 159.39 USD. This implies a price increase of 38.31% is expected in the next year compared to the current price of 115.24. Check the PERKINELMER INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is PERKINELMER INC worth?
PERKINELMER INC (PKI) has a market capitalization of 14.57B USD. This makes PKI a Large Cap stock.
How many employees does PERKINELMER INC have?
PERKINELMER INC (PKI) currently has 16700 employees.
What are the support and resistance levels for PERKINELMER INC (PKI) stock?
PERKINELMER INC (PKI) has a resistance level at 127.47. Check the full technical report for a detailed analysis of PKI support and resistance levels.
Is PERKINELMER INC (PKI) expected to grow?
The Revenue of PERKINELMER INC (PKI) is expected to decline by -31.32% in the next year. Check the estimates tab for more information on the PKI EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy PERKINELMER INC (PKI) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of PKI, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of PKI, evaluating the profitability, health, valuation and growth aspects
- PERKINELMER INC (PKI) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- PERKINELMER INC (PKI) Sales and EPS estimates to see what analysts future expectations are.
- PERKINELMER INC (PKI) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- PERKINELMER INC (PKI) Insider and Institutional Ownership to learn about the owners and their transactions.
- PERKINELMER INC (PKI) Stock Chart to make your own analysis
- PERKINELMER INC (PKI) Latest news and press-releases to stay up to date.
Does PERKINELMER INC (PKI) stock pay dividends?
PKI does not pay a dividend.
When does PERKINELMER INC (PKI) report earnings?
PERKINELMER INC (PKI) will report earnings on 2023-07-31, before the market open.
What is the Price/Earnings (PE) ratio of PERKINELMER INC (PKI)?
The PE ratio for PERKINELMER INC (PKI) is 14.51. This is based on the reported non-GAAP earnings per share of 7.94 and the current share price of 115.24 USD. Check the full fundamental report for a full analysis of the valuation metrics for PKI.
PKI Technical Analysis
PKI Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to PKI. PKI scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
PKI Financial Highlights
Over the last trailing twelve months PKI reported a non-GAAP Earnings per Share(EPS) of 7.94. The EPS decreased by -30.47% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 16.32% | ||
| ROA | 5.28% | ||
| ROE | 10.11% | ||
| Debt/Equity | 0.53 |
PKI Forecast & Estimates
20 analysts have analysed PKI and the average price target is 159.39 USD. This implies a price increase of 38.31% is expected in the next year compared to the current price of 115.24.
For the next year, analysts expect an EPS growth of -34.36% and a revenue growth -31.32% for PKI